Aquestive Therapeutics Inc. 持续推进Anaphylm在加拿大及欧盟的监管申报进程

美股速递
Mar 30

Aquestive Therapeutics Inc. 近日宣布,其针对Anaphylm(肾上腺素舌下膜)的监管申报工作,在加拿大与欧洲联盟两大关键市场正稳步推进。公司致力于通过监管审批途径,将这一创新疗法引入更广阔的国际市场。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10